INHBE and neoplasm: The heterogeneity in between TMA cores, at least for activin staining was low (difference > 1 point in either intensity or positive tumor cell sub-scores in 2,4% of cases), and the tumor infiltrating lymphocyte working group sees TMAs as adequate tool for rapid evaluation of large clinical cohorts [32].